Center for Sleep Medicine, Croix-Rousse Hospital, Hospices Civils de Lyon, Lyon, France; Grenoble Alpes University, HP2 Laboratory (Hypoxia Pathophysiology), INSERM U1300 Grenoble, France; Lyon Neuroscience Research Center, PAM Team, INSERM U1028 / CNRS UMR 5292 / Lyon 1 University, Lyon, France.
Sommeil, Addiction et Neuropsychiatrie, Université de Bordeaux, SANPSY, USR 3413, F-33000 Bordeaux, France.
Sleep Med. 2024 Oct;122:221-229. doi: 10.1016/j.sleep.2024.08.001. Epub 2024 Aug 23.
Sleepiness in patients with obstructive sleep apnea (OSA) is associated with accidental and economic burden, as well as cardiovascular risk. Despite OSA treatment, 10-28 % of patients report residual sleepiness. Its determinants, as well as those of objective impaired alertness remain poorly known. In this study, we investigated factors associated with residual subjective sleepiness and objective impaired alertness in patients treated for OSA.
Consecutive OSA treated patients referred for maintenance of wakefulness tests (MWT) at a tertiary university center were recruited between 2017 and 2020. Clinical data and polysomnography parameters were compared between patients with vs without subjective sleepiness (Epworth Sleepiness Scale, ESS≥11) and those with vs without impaired alertness (at least one trial with sleep onset on MWT). A multivariate logistic model was used to assess explanatory variables of MWT and ESS results.
We included 141 patients, of whom 12.8 % had both subjective sleepiness and objective impaired alertness, 17.7 % objective impaired alertness only and 9.2 % subjective sleepiness only. Self-reported history of car accident/near miss, smoking history and ESS≥11 were significantly associated with objective impaired alertness whereas residual Apnea-hypopnea Index and CPAP use were not. The only significant variable associated with ESS at the time of MWT evaluation was initial ESS. Patients with objective impaired alertness only were more often smokers (52 % vs 19 %, p = 0.01), had a higher body mass index (BMI) (32 vs 29 kg/m, p = 0.05), and showed lower initial ESS (11 vs 13, p < 0.01).
More than one third of OSA treated patients referred for MWT have objective impaired alertness and/or subjective sleepiness. Our findings highlight the need for a comprehensive medical assessment including accident history, subjective sleepiness and comorbidities. Particular attention should be paid to smoking patients with high BMI, who are at risk of impaired alertness with no report of subjective sleepiness.
阻塞性睡眠呼吸暂停(OSA)患者的嗜睡与意外和经济负担以及心血管风险相关。尽管进行了 OSA 治疗,仍有 10-28%的患者报告存在残余嗜睡。其决定因素以及客观警觉受损的决定因素仍知之甚少。在这项研究中,我们调查了治疗 OSA 后患者残余主观嗜睡和客观警觉受损的相关因素。
我们于 2017 年至 2020 年期间连续招募了在三级大学中心进行维持清醒测试(MWT)的 OSA 治疗患者。比较了有与无主观嗜睡(Epworth 嗜睡量表,ESS≥11)以及有与无警觉受损(MWT 至少有一次出现睡眠起始)的患者之间的临床数据和多导睡眠图参数。使用多变量逻辑模型评估 MWT 和 ESS 结果的解释变量。
我们纳入了 141 名患者,其中 12.8%既有主观嗜睡又有客观警觉受损,17.7%仅有客观警觉受损,9.2%仅有主观嗜睡。自我报告的车祸/差点发生车祸的病史、吸烟史和 ESS≥11 与客观警觉受损显著相关,而残余的呼吸暂停低通气指数和 CPAP 使用则不然。在 MWT 评估时与 ESS 唯一显著相关的变量是初始 ESS。仅有客观警觉受损的患者中,吸烟者更多(52%比 19%,p=0.01),体重指数(BMI)更高(32 比 29kg/m,p=0.05),初始 ESS 更低(11 比 13,p<0.01)。
超过三分之一的接受 MWT 检查的 OSA 治疗患者存在客观警觉受损和/或主观嗜睡。我们的研究结果强调了需要进行全面的医疗评估,包括意外事故史、主观嗜睡和合并症。特别需要注意吸烟、BMI 高的患者,他们存在警觉受损而无主观嗜睡的风险。